The World Mitochondria Society (WMS) is preparing for its annual Targeting Mitochondria 2024 conference, which will focus on innovative strategies to “charge” cells by supplying them with extra mitochondria to enhance cellular function and combat diseases.
Sequencing in Advanced Urothelial Carcinoma
The indication for sacituzumab govitecan (Trodelvy) in previously treated patients with locally advanced or metastatic urothelial cancer was withdrawn last month after the drug failed